Citation Impact
Citing Papers
Programmed cell death 1 inhibits inflammatory helper T-cell development through controlling the innate immune response
2013 StandoutNobel
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
2005 Standout
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
2003 StandoutScience
Homeostatic maintenance of natural Foxp3 + CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization
2005 StandoutNobel
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
2009 Standout
Myelin/oligodendrocyte glycoprotein (MOG) expression is associated with myelin deposition
1996
Functional Bowel Disorders
2006 Standout
Differences between T‐cell reactivities to major myelin protein‐derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls
2001
Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study
1999
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 Standout
Treatment of multiple sclerosis with Copolymer-1 (Copaxone®): implicating mechanisms of Th1 to Th2/Th3 immune-deviation
1998
Myasthenia Gravis
2016 Standout
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
Bowel Disorders
2016 Standout
Sjögren's syndrome
2005 Standout
Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: A case for antigen-specific antibody mediation
1999
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Chronic inflammation in the etiology of disease across the life span
2019 Standout
A new approach for evaluating antigen-specific T cell responses to myelin antigens during the course of multiple sclerosis
2003
From classic to spontaneous and humanized models of multiple sclerosis: Impact on understanding pathogenesis and drug development
2014
Belching, bloating, and flatulence
1997
Decreased severity of myelin oligodendrocyte glycoprotein peptide 33 – 35-induced experimental autoimmune encephalomyelitis in mice with a disrupted TCR δ chain gene
1999
Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.
1995
Integrins Form an Expanding Diffusional Barrier that Coordinates Phagocytosis
2016 StandoutNobel
Multiple sclerosis: a unique immunopathological syndrome of the central nervous system
1995
Multiple sclerosis candidate autoantigens except myelin oligodendrocyte glycoprotein are transcribed in human thymus
2002
Management of lupus erythematosus: recent insights
2002
Porphyrias
2010 Standout
Increased immunoreactivity to two overlapping peptides of myelin proteolipid protein in multiple sclerosis
1997
IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells
2007 StandoutNature
T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls
2001
Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+ multiple sclerosis
1998
TGF-β: Receptors, Signaling Pathways and Autoimmunity
2001
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial
2000 Standout
Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)‐derived peptide: Preliminary analysis of MOG T cell epitopes
1995
Multiple sclerosis
2008 Standout
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Acceleration of Experimental Autoimmune Encephalomyelitis in Interleukin-10-Deficient Mice: Roles of Interleukin-10 in Disease Progression and Recovery
1998
Controlled treatment trials in the irritable bowel syndrome: A critique
1988
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
2006 StandoutNature
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H‐2b mice: Fine specificity and T cell receptor Vβ expression of encephalitogenic T cells
1995
Interleukin-1 and IL-23 Induce Innate IL-17 Production from γδ T Cells, Amplifying Th17 Responses and Autoimmunity
2009 Standout
Obesity in autoimmune diseases: Not a passive bystander
2014
Immunopathology of multiple sclerosis
2015 Standout
Specificity of autoantibodies to epitopes of myelin proteins in multiple sclerosis
2002
CD4 T‐cell epitopes of human α B‐crystallin
2004
Hygiene and other early childhood influences on the subsequent function of the immune system
2014
Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
2012 Standout
Glycoproteins of myelin sheaths
1997
The immunology of stroke: from mechanisms to translation
2011 Standout
Microbiota, Immunoregulatory Old Friends and Psychiatric Disorders
2014
A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes: A New Resource for Understanding Brain Development and Function
2008 Standout
Distinct and Nonredundant In Vivo Functions of IFNAR on Myeloid Cells Limit Autoimmunity in the Central Nervous System
2008
The central nervous sytem-specific myelin oligodendrocytic basic protein (MOBP) is encephalitogenic and a potential target antigen in multiple sclerosis (MS)
2000
Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis
2000
The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat
1995
Minireview: Autoimmune responses to myelin proteolipid protein
1994
Multiple Sclerosis
2000 Standout
Regulation of type I interferon responses
2013 Standout
HPRT mutant T-cell lines from multiple sclerosis patients recognize myelin proteolipid protein peptides
1997
Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein
1999
In vitro evidence that subcutaneous administration of glatiramer acetate induces hyporesponsive T cells in patients with multiple sclerosis
2003
Golli-MBP gene in multiple sclerosis susceptibility
1998
Synergistic immunomodulatory effects of interferon‐β1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing‐remitting multiple sclerosis
1998
Antigen Presentation in the CNS by Myeloid Dendritic Cells Drives Progression of Relapsing Experimental Autoimmune Encephalomyelitis
2007
Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome
2000
HLA-DP: A Class II Restriction Molecule Involved in Epitope Spreading During the Development of Multiple Sclerosis
1998
Binding of complement component Clq to myelin oligodendrocyte glycoprotein: A novel mechanism for regulating CNS inflammation
1997
From inflammation to sickness and depression: when the immune system subjugates the brain
2007 Standout
Copolymer 1 inhibits chronic relapsing experimental allergic encephalomyelitis induced by proteolipid protein (PLP) peptides in mice and interferes with PLP-specific T cell responses
1996
American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation
2014
Physical mapping of the human and mouse MOG gene at the distal end of the MHC class Ib region
1995
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
2004 Standout
T‐ and B‐cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis
2001
The role of inflammation in depression: from evolutionary imperative to modern treatment target
2015 Standout
Multiple sclerosis
2002 Standout
Myelin Oligodendrocyte Glycoprotein–specific T Cell Receptor Transgenic Mice Develop Spontaneous Autoimmune Optic Neuritis
2003
Irritable Bowel Syndrome
2015 Standout
Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis
2013
Mechanisms of action of glatiramer acetate in multiple sclerosis
2001
Fibrinogen binds IgG antibody and enhances IgG-mediated phagocytosis1
2008
Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides.
1994
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Policy: NIH to balance sex in cell and animal studies
2014 StandoutNature
Antagonizing the α4β1 Integrin, but Not α4β7, Inhibits Leukocytic Infiltration of the Central Nervous System in Rhesus Monkey Experimental Autoimmune Encephalomyelitis
2013
Interleukin‐6 functions in autoimmune encephalomyelitis: a study in gene‐targeted mice
1998
IL-17 and Th17 Cells
2009 Standout
Type I Diabetes and Multiple Sclerosis Patients Target Islet Plus Central Nervous System Autoantigens; Nonimmunized Nonobese Diabetic Mice Can Develop Autoimmune Encephalitis
2001
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
2004 StandoutNobel
IFN-β Gene Deletion Leads to Augmented and Chronic Demyelinating Experimental Autoimmune Encephalomyelitis
2003
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
IMMUNOLOGY OF MULTIPLE SCLEROSIS
2005 Standout
Oligodendrocyte-Specific Protein Peptides Induce Experimental Autoimmune Encephalomyelitis in SJL/J Mice
1999
Pharmacologic Treatment of the Irritable Bowel Syndrome
2000
CSF-1–Dependent Red Pulp Macrophages Regulate CD4 T Cell Responses
2011 StandoutNobel
T Cell Epitopes of Human Myelin Oligodendrocyte Glycoprotein Identified in HLA-DR4 (DRB1*0401) Transgenic Mice Are Encephalitogenic and Are Presented by Human B Cells
2001
Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
2001 Standout
Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis.
1994
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Myelin-Associated Oligodendrocytic Basic Protein: Identification of an Encephalitogenic Epitope and Association with Multiple Sclerosis
2000
Late Complications of Immune Deviation Therapy in a Nonhuman Primate
1996 Science
Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3
2003 Standout
Increased CD8+ Cytotoxic T Cell Responses to Myelin Basic Protein in Multiple Sclerosis
2004
Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4+T cells
2000 StandoutNobel
ORAL TOLERANCE FOR THE TREATMENT OF AUTOIMMUNE DISEASES
1997
Oral tolerance.
1994
Estrogen receptor‐β ligand treatment after disease onset is neuroprotective in the multiple sclerosis model
2013
Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response
2004 Standout
Sex Differences in Long-Term Quality of Life Among Survivors After Stroke in the INSTRUCT
2019
Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain
2011 StandoutNobel
CD8+ T Cells Are a Biologically Relevant Source of Macrophage Inflammatory Protein-1α In Vivo
1999 StandoutNobel
Specific Proliferation Towards Myelin Antigens in Patients with Multiple Sclerosis During a Relapse
2002
IL-6-Deficient Mice Are Resistant to Experimental Autoimmune Encephalomyelitis: Roles of IL-6 in the Activation and Differentiation of Autoreactive T Cells
1998
The Human T Cell Response to Myelin Oligodendrocyte Glycoprotein: A Multiple Sclerosis Family-Based Study
2002
High Immunogenicity of Intracellular Myelin Oligodendrocyte Glycoprotein Epitopes
2002
Physiology of Microglia
2011 Standout
Disease modifying therapies in multiple sclerosis: Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED]
2002
Recommendations for the Diagnosis and Treatment of the Acute Porphyrias
2005
Works of Ron Milo being referenced
“Prokinetic” Treatment of Constipation-Predominant Irritable Bowel Syndrome
1991
Additive effects of copolymer-1 and interferon β-1b on the immune response to myelin basic protein
1995
Therapeutic strategies targeting B-cells in multiple sclerosis
2016
Multiple sclerosis: Geoepidemiology, genetics and the environment
2009
Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: Reactivity to the extracellular domain of MOG is directed against three main regions
1997
Acute myocardial infarction associated with high dose intravenous immunoglobulin infusion for autoimmune disorders. A study of four cases
2000
Effect of Propranolol and IFN-β on the Induction of MHC Class II Expression and Cytokine Production by IFN-γ in THP-1 Human Monocytic Cells
1998
Stroke in the Very Elderly: Characteristics and Outcome in Patients Aged ≥85 Years with a First-Ever Ischemic Stroke
2012
Revised diagnostic criteria of multiple sclerosis
2014
Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein.
1993
Glatiramer acetate blocks the activation of THP-1 cells by interferon-γ
1998
Acute intermittent porphyria in pregnancy
1989
Glatiramer Acetate or Interferon-?? for Multiple Sclerosis?
1999
Use of the peripheral dopamine antagonist, domperidone, in the management of gastrointestinal symptoms in patients with irritable bowel syndrome
1980
Synthetic copolymer 1 inhibits human T-cell lines specific for myelin basic protein.
1992